Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy ...

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a ...

Results from a phase 2b trial (ClinicalTrials.gov Identifier: NCT04707313) showed treatment with danuglipron led to statistically significant reductions in body weight at all tested doses (40mg, 80mg, ...

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Viking Therapeutics shares rose Monday morning before reversing course and declining after reporting the latest results from ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

Actor Vidya Balan recently revealed that her weight gain struggles were due to inflammation, which improved after she ...

When you reduce your body weight, an estimated 20 to 40 percent of the total lost ... It compared people in a diet-only group ...

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.

We can back into this math to arrive at 1,996k subscribers ex-GLP-1, or put in other words, only ~50k of this quarter's net ...

Lexicon (LXRX) announced the peer-reviewed Journal of American Society of Nephrology, or JASN, has published a research paper analyzing the ...

After years of talking about your weight loss plan, you’ve finally decided to take action. You hired a personal trainer, have ...